Five cylindrical glass ampoules (c-g) with icicle-shaped melted glass seals in a moulded plastic tray (b) inside a cardboard sleeve (a) with a paper leaflet (h).
Five cylindrical glass ampoules (c-g) with icicle-shaped melted glass seals in a moulded plastic tray (b) inside a cardboard sleeve (a) with a paper leaflet (h).
Number Of Parts
8
Part Names
a - sleeve - Size: Length 8.1 cm x Width 6.7 cm x Depth 1.4 cm
b -tray - Size: Length 7.9 cm x Width 6.7 cm x Depth 1.4 cm
c-g - ampoule - Size: Length 5.3 cm x Diam. 1.0 cm
h -leaflet (unfolded) - Size: Length 21.3 cm x Width 10.1 cm
(a) Top: "10 (2 x 5) 1 CC. No. 192 // AMPOULES // ADRENALIN® IN OIL // STERILE SUSPENSION, EPINEPHRINE // C.S.O. // 1:500 // Each cc. contains: Adrenalin® (epinephrine, P.D. & Co.) 2 mg. // Peanut Oil [76 dots] q.s. // LYX // 2-3 // PARKE-DAVIS Lot BM214 // Stock 3-192-10"; front: "AMPOULES ADRENALIN® IN OIL 1 CC."; bottom: "For use when prolonged vasoconstrictor action of Adrenalin® is desired. // FOR INTRAMUSCULAR USE ONLY // Dose – 0.2 to 1.5 cc. See package insert for more detailed // information. // SHAKE THOROUGHLY BEFORE USE // Transfer of content from ampoule to syringe is facilitated if the ampoule is // warmed somewhat in water. Before opening the ampoule it should be shaken // thoroughly to ensure uniform suspension of the Adrenalin®. // CAUTION: Administer with caution to elderly people, to those with cardiovascular // disease, diabetes or hyperthyroidism, and to individuals having high blood // pressure. // PROTECT FROM LIGHT // [above text repeated in French] // Parke, Davis & Company, Ltd., Brockville, Ontario"; back: identical to front; (b) "PARKE-DAVIS // B"; (c-g) "1 CC. No. 192 // ADRENALIN® IN OIL // STERILE SUSPENSION, // EPINEPHRINE C.S.O. // 1:500 // SHAKE WELL // FOR I.M. USE ONLY // Parke, Davis & Co., Ltd. // Lot BM214 [labels cover text printed directly on the ampoules; this text appears to be the same as that on the lables except for the lot number]"; (h) "ADRENALIN® IN OIL // 1:500 // PARKE-DAVIS // STERILE SUSPENSION, EPINEPHRINE C.S.D. // DESCRIPTION // [text follows] // ACTION // [text follows] // INDICATIONS // [text follows] // CONTRAINDICATIONS // [text follows] // WARNING // [text follows] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // ADMINISTRATION AND DOSAGE // [text follows] // PACKAGE INFORMATION // [text follows] // PARKE-DAVIS // PARKE, DAVIS & COMPANY, LTD., BROCKVILLE, ONTARIO // May, 1970 [French translation is printed alongside English text throughout]"